Understanding Lung Cancer related risk factors and their Impact

HORIZON.2.1HORIZON-RIAID: 101096473
EC Contribution
โ‚ฌ135,169
Consortium Size
24 orgs
โ–ถSummary

Lung Cancer (LC) is the biggest cancer killer worldwide, with five-year survival following diagnosis varying between 5% to 25%. Though tobacco smoking has long been recognized as the major risk factor for LC, many cases (incl. LC patients that are non-smokers) cannot be explained by this reason. In this sense, LUCIA aims to establish a novel toolbox for discovering and understanding new risk factors that contribute to LC development. The toolbox encompasses the analysis of three aspects: (i) personal risk factors, which include a personโ€™s exposure to chemical pollutants and behavioural and lifestyle factors; (ii) external risk factors, such as urban, built and transport environments, social aspects and climate; and (iii) biological responses to the personal and external risk factors, including changes in genetics, epigenetics, metabolism and aging. Key components of the toolbox for analysing personal and external risk factors include retrospective and prospective cohort databases, AI models, wearable devices, novel non-invasive sensors, and multi-omics. Together, these tools will be used to identify the effects of a wide range of environmental, biological, demographic, community and individual-level risk factors associated with the formation of LC. Molecular changes associated with the risk factors identified by this set of tools will then be validated by cell and molecular biology methods and through in vivo analysis. The impact of the identified personal and external risk factors and the associated biological responses will be then validated in three clinical use cases: general population risk assessment and screening, precision screening of high-risk populations, and digital diagnostics. The resulting evidence within LUCIA will be translated into policymaking recommendations, with the aim to implement them in a screening program for LC. This action is part of the Cancer Mission cluster of projects on โ€˜Understanding'.

Consortium (24)

๐Ÿ‡ฎ๐Ÿ‡ฑ TECHNION - ISRAEL INSTITUTE OF TECHNOLOGYIL
coordinator
๐Ÿ‡ช๐Ÿ‡ธ ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOBIZKAIAES
partner
๐Ÿ‡ช๐Ÿ‡ธ BILBOMATICA SAES
partner
๐Ÿ‡ง๐Ÿ‡ช CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGEBE
partner
๐Ÿ‡ช๐Ÿ‡ธ CONSORCIO PARA LA EXPLOTACION DEL CENTRO NACIONAL DE ANALISIS GENOMICOES
partner
๐Ÿ‡ฉ๐Ÿ‡ช DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERGDE
partner
๐Ÿ‡ฎ๐Ÿ‡น DEXAI - Etica ArtificialeIT
partner
๐Ÿ‡น๐Ÿ‡ท EMODA YAZILIM VE DANISMANLIK SANAYITICARET LIMITED SIRKETITR
partner
๐Ÿ‡ง๐Ÿ‡ช EUROPEAN HOSPITAL AND HEALTHCARE FEDERATIONBE
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACIO CENTRE DE REGULACIO GENOMICAES
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)ES
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACION CENTRO DE TECNOLOGIAS DE INTERACCION VISUAL Y COMUNICACIONES VICOMTECHES
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACION PARA LA GESTION DE LA INVESTIGACION EN SALUD DE SEVILLAES
partner
๐Ÿ‡ฑ๐Ÿ‡ป LATVIJAS UNIVERSITATELV
partner
๐Ÿ‡ฎ๐Ÿ‡ฑ NANOSE MEDICAL LTDIL
partner
๐Ÿ‡ฎ๐Ÿ‡ฑ PRONAT INDUTRIES LTDIL
partner
๐Ÿ‡ฉ๐Ÿ‡ช RUPRECHT-KARLS-UNIVERSITAET HEIDELBERGDE
partner
๐Ÿ‡ช๐Ÿ‡ธ SERVICIO ANDALUZ DE SALUDES
partner
๐Ÿ‡ช๐Ÿ‡ธ Servicio Vasco de Salud OsakidetzaES
partner
๐Ÿ‡ฎ๐Ÿ‡ฑ TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTDIL
partner
๐Ÿ‡ง๐Ÿ‡ช TIMELEXBE
partner
๐Ÿ‡ช๐Ÿ‡ธ UNIVERSIDAD POLITECNICA DE MADRIDES
partner
๐Ÿ‡ฌ๐Ÿ‡ง UNIVERSITY OF ULSTERGB
partner
๐Ÿ‡ณ๐Ÿ‡ฑ YAGHMA B.V.NL
partner